Unlocking Shear Protection for High-Yield mAb Production
Biopharmaceutical innovation is rapidly evolving, with increasing demand for more efficient and scalable manufacturing solutions to accelerate the speed to market for next-generation biologic drugs. At BPI West, BASF and Cytiva will present a joint collaboration, combining BASF’s expertise in raw material functionality with Cytiva’s deep knowledge in bioprocessing to address key production challenges.
In our presentation we share insights into science-based solutions for monoclonal antibody (mAb) production, process efficiency, and shear protection in bioreactors. Discover how the synergy between high-quality raw materials and optimized bioprocessing strategies can enhance cell viability, improve yields, and ensure high-quality biologics reach patients faster and more cost-effectively.
See related videos: Biopharma